Tigecycline Galenicum 50mg powder for solution for infusion

국가: 몰타

언어: 영어

출처: Medicines Authority

지금 구매하세요

Download 환자 정보 전단 (PIL)
27-06-2023
Download 제품 특성 요약 (SPC)
27-06-2023
Download 공공 평가 보고서 (PAR)
24-11-2021

유효 성분:

TIGECYCLINE

제공처:

Galenicum Health, S.L.U Calle Sant Gabriel, 50 Esplugues de Llobregat 08950 Barcelona, Spain

ATC 코드:

J01AA12

INN (국제 이름):

TIGECYCLINE 10 mg/ml

약제 형태:

POWDER FOR SOLUTION FOR INFUSION

구성:

TIGECYCLINE 10 mg/ml

처방전 유형:

POM

치료 영역:

ANTIBACTERIALS FOR SYSTEMIC USE

제품 요약:

Licence number in the source country: NOT APPLICAPABLE

승인 상태:

Authorised

승인 날짜:

2020-02-06

환자 정보 전단

                                Page
1
of
6
PACKAGE LEAFLET: INFORMATION FOR THE USER
TIGECYCLINE GALENICUM 50 MG POWDER FOR SOLUTION FOR INFUSION
Tigecycline
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE
BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or nurse.
-
If you get any side effects, talk to your doctor, or nurse. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Tigecycline Galenicum is and what it is used for
2.
What you need to know before you receive Tigecycline Galenicum
3.
How Tigecycline Galenicum is given
4.
Possible side effects
5.
How to store Tigecycline Galenicum
6.
Contents of the pack and other information
1.
WHAT TIGECYCLINE GALENICUM IS AND WHAT IT IS USED FOR
Tigecycline is an antibiotic of the glycylcycline group that works by
stopping the growth of
bacteria that cause infections.
Your doctor prescribed Tigecycline Galenicum because you or your child
at least 8 years old has
one of the following types of serious infections:
•
Complicated infection of the skin and soft tissues (the tissue below
the skin), excluding
diabetic foot infections.
•
Complicated infection in the abdomen
Tigecycline is only used when your doctor thinks other antibiotics are
not suitable.
2.
WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE TIGECYCLINE GALENICUM
DO NOT USE TIGECYCLINE GALENICUM
•
If you are allergic to tigecycline, or any of the other ingredients of
this medicine (listed
in section 6). If you are allergic to tetracycline class antibiotics
(e.g., minocycline, doxycycline,
etc.), you may be allergic to tigecycline.
WARNINGS AND PRECAUTIONS
Talk to your doctor or nurse before receiving Tigecycline Galenicum:
•
If you have poor or slow wound healing.
•
If you are suffering from diarrhoea before you are given Tigecycline.
If you develop
diarrhoea during or after your treatment, tell your doctor at once. Do
not take any
diarrhoea medicine 
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                Page
1
of
15
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
Tigecycline Galenicum 50 mg powder for solution for infusion
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial contains 50 mg of tigecycline.
After reconstitution, 1 ml contains 10 mg of tigecycline.
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Powder for solution for infusion.
Orange to orange-red, lyophilized cake or powder, free of visible
evidence of contamination.
The pH of the reconstituted solution ranges between 4.0 and 6.0, and
the osmolarity ranges between
240 – 320 mOsm/Kg depending on the reconstitution solvent.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Tigecycline is indicated in adults and in children from the age of
eight years for the treatment of the
following infections (see sections 4.4 and 5.1):
• Complicated skin and soft tissue infections (cSSTI), excluding
diabetic foot infections (see section
4.4)
• Complicated intra-abdominal infections (cIAI)
Tigecycline should be used only in situations where other alternative
antibiotics are not suitable (see
sections 4.4, 4.8 and 5.1).
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults _
The recommended dose for adults is an initial dose of 100 mg followed
by 50 mg every 12 hours for 5
to 14 days.
The duration of therapy should be guided by the severity, site of the
infection, and the patient’s
clinical response.
_ _
_Children and adolescents (8 to 17 years of age) _
Tigecycline is only to be used to treat patients aged 8 years and
older after consultation with a
physician with appropriate experience in the management of infectious
diseases.
Page
2
of
15
Children aged 8 to <12 years: 1.2 mg/kg of tigecycline every 12 hours
intravenously to a
maximum dose of 50 mg every 12 hours for 5 to 14 days.
Adolescents aged 12 to <18 years: 50 mg of tigecycline every 12 hours
for 5 to 14 days.
_ _
_Elderly population _
No dosage 
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림